NEW YORK (TheStreet) -- Shares of Tenet Healthcare (THC - Get Report) were retreating in after-hours trading on Monday as the Dallas-based hospital operator reported lower-than-expected 2016 third-quarter earnings and issued a fourth quarter earnings forecast that missed analysts' estimates.
After today's closing bell, Tenet posted adjusted earnings of 16 cents per share, which fell short of analysts' expected 19 cents per share.
The company posted net operating revenues of $4.85 billion, above Wall Street's projected $4.78 billion.
Tenet expects to report adjusted earnings of 17 cents to 22 cents per share in the fourth quarter, while analysts are looking for adjusted earnings of 54 cents per share for the quarter.
Revenue for the fourth quarter is forecast to be in the range of $4.90 billion to $5.00 billion. Analysts surveyed by FactSet are looking for $4.94 billion in revenue.
For the full year, Tenet now expects to report adjusted earnings of $1.16 to $1.21 per share, down from its prior range of $1.32 to $1.67 per share. Analysts surveyed by FactSet are looking for adjusted earnings of $1.54 per share.
The company forecast revenue to be between $19.65 billion and $19.80 billion, while analysts surveyed by FactSet are modeling $19.65 billion for the year.
More than 2.72 million of Tenet's shares changed hands today vs. its average 30-day volume of 2.61 million shares per day.
Separately, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
The team rates Tenet Healthcare as a Sell with a ratings score of D+. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk, disappointing return on equity, poor profit margins and generally disappointing historical performance in the stock itself.
You can view the full analysis from the report here: THC